Global Autologous Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 60300
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Autologous Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Autologous Cell Therapy size is estimated to be USD 11650 million in 2026 from USD 7441.3 million in 2020, with a change XX% between 2020 and 2021. The global Autologous Cell Therapy market size is expected to grow at a CAGR of 11.9% for the next five years.

Market segmentation

Autologous Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Bone Marrow

Epidermis

Market segment by Application, can be divided into

Neurology

Orthopedics

Cancer

Wound Healing

Other

Market segment by players, this report covers

BioTime

Pharmicell

BrainStorm Cell Therapeutics

Opexa Therapeutics

Vericel Corporation

Regeneus

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Autologous Cell Therapy

1.2 Classification of Autologous Cell Therapy by Type

1.2.1 Overview: Global Autologous Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Autologous Cell Therapy Revenue Market Share by Type in 2020

1.2.3 Bone Marrow

1.2.4 Epidermis

1.3 Global Autologous Cell Therapy Market by Application

1.3.1 Overview: Global Autologous Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Neurology

1.3.3 Orthopedics

1.3.4 Cancer

1.3.5 Wound Healing

1.3.6 Other

1.4 Global Autologous Cell Therapy Market Size & Forecast

1.5 Global Autologous Cell Therapy Market Size and Forecast by Region

1.5.1 Global Autologous Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Autologous Cell Therapy Market Size by Region, (2016-2021)

1.5.3 North America Autologous Cell Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Autologous Cell Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Autologous Cell Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Autologous Cell Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Autologous Cell Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Autologous Cell Therapy Market Drivers

1.6.2 Autologous Cell Therapy Market Restraints

1.6.3 Autologous Cell Therapy Trends Analysis

2 Company Profiles

2.1 BioTime

2.1.1 BioTime Details

2.1.2 BioTime Major Business

2.1.3 BioTime Autologous Cell Therapy Product and Solutions

2.1.4 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 BioTime Recent Developments and Future Plans

2.2 Pharmicell

2.2.1 Pharmicell Details

2.2.2 Pharmicell Major Business

2.2.3 Pharmicell Autologous Cell Therapy Product and Solutions

2.2.4 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Pharmicell Recent Developments and Future Plans

2.3 BrainStorm Cell Therapeutics

2.3.1 BrainStorm Cell Therapeutics Details

2.3.2 BrainStorm Cell Therapeutics Major Business

2.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Product and Solutions

2.3.4 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 BrainStorm Cell Therapeutics Recent Developments and Future Plans

2.4 Opexa Therapeutics

2.4.1 Opexa Therapeutics Details

2.4.2 Opexa Therapeutics Major Business

2.4.3 Opexa Therapeutics Autologous Cell Therapy Product and Solutions

2.4.4 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Opexa Therapeutics Recent Developments and Future Plans

2.5 Vericel Corporation

2.5.1 Vericel Corporation Details

2.5.2 Vericel Corporation Major Business

2.5.3 Vericel Corporation Autologous Cell Therapy Product and Solutions

2.5.4 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Vericel Corporation Recent Developments and Future Plans

2.6 Regeneus

2.6.1 Regeneus Details

2.6.2 Regeneus Major Business

2.6.3 Regeneus Autologous Cell Therapy Product and Solutions

2.6.4 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Regeneus Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Autologous Cell Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Autologous Cell Therapy Players Market Share

3.2.2 Top 10 Autologous Cell Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Autologous Cell Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Autologous Cell Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Autologous Cell Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Autologous Cell Therapy Revenue Market Share by Application (2016-2021)

5.2 Autologous Cell Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Autologous Cell Therapy Revenue by Type (2016-2026)

6.2 North America Autologous Cell Therapy Revenue by Application (2016-2026)

6.3 North America Autologous Cell Therapy Market Size by Country

6.3.1 North America Autologous Cell Therapy Revenue by Country (2016-2026)

6.3.2 United States Autologous Cell Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Autologous Cell Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Autologous Cell Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Autologous Cell Therapy Revenue by Type (2016-2026)

7.2 Europe Autologous Cell Therapy Revenue by Application (2016-2026)

7.3 Europe Autologous Cell Therapy Market Size by Country

7.3.1 Europe Autologous Cell Therapy Revenue by Country (2016-2026)

7.3.2 Germany Autologous Cell Therapy Market Size and Forecast (2016-2026)

7.3.3 France Autologous Cell Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Autologous Cell Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Autologous Cell Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Autologous Cell Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Autologous Cell Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Autologous Cell Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Autologous Cell Therapy Market Size by Region

8.3.1 Asia-Pacific Autologous Cell Therapy Revenue by Region (2016-2026)

8.3.2 China Autologous Cell Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Autologous Cell Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Autologous Cell Therapy Market Size and Forecast (2016-2026)

8.3.5 India Autologous Cell Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Autologous Cell Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Autologous Cell Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Autologous Cell Therapy Revenue by Type (2016-2026)

9.2 South America Autologous Cell Therapy Revenue by Application (2016-2026)

9.3 South America Autologous Cell Therapy Market Size by Country

9.3.1 South America Autologous Cell Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Autologous Cell Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Autologous Cell Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Autologous Cell Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Autologous Cell Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Autologous Cell Therapy Market Size by Country

10.3.1 Middle East & Africa Autologous Cell Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Autologous Cell Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Autologous Cell Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Autologous Cell Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Autologous Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Autologous Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Autologous Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Autologous Cell Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Autologous Cell Therapy Revenue Market Share by Region (2021-2026)

Table 6. BioTime Corporate Information, Head Office, and Major Competitors

Table 7. BioTime Major Business

Table 8. BioTime Autologous Cell Therapy Product and Solutions

Table 9. BioTime Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Pharmicell Corporate Information, Head Office, and Major Competitors

Table 11. Pharmicell Major Business

Table 12. Pharmicell Autologous Cell Therapy Product and Solutions

Table 13. Pharmicell Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. BrainStorm Cell Therapeutics Corporate Information, Head Office, and Major Competitors

Table 15. BrainStorm Cell Therapeutics Major Business

Table 16. BrainStorm Cell Therapeutics Autologous Cell Therapy Product and Solutions

Table 17. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Opexa Therapeutics Corporate Information, Head Office, and Major Competitors

Table 19. Opexa Therapeutics Major Business

Table 20. Opexa Therapeutics Autologous Cell Therapy Product and Solutions

Table 21. Opexa Therapeutics Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Vericel Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Vericel Corporation Major Business

Table 24. Vericel Corporation Autologous Cell Therapy Product and Solutions

Table 25. Vericel Corporation Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Regeneus Corporate Information, Head Office, and Major Competitors

Table 27. Regeneus Major Business

Table 28. Regeneus Autologous Cell Therapy Product and Solutions

Table 29. Regeneus Autologous Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Global Autologous Cell Therapy Revenue (USD Million) by Players (2019-2021)

Table 31. Global Autologous Cell Therapy Revenue Share by Players (2019-2021)

Table 32. Breakdown of Autologous Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Autologous Cell Therapy Players Head Office, Products and Services Provided

Table 34. Autologous Cell Therapy Mergers & Acquisitions in the Past Five Years

Table 35. Autologous Cell Therapy New Entrants and Expansion Plans

Table 36. Global Autologous Cell Therapy Revenue (USD Million) by Type (2016-2021)

Table 37. Global Autologous Cell Therapy Revenue Share by Type (2016-2021)

Table 38. Global Autologous Cell Therapy Revenue Forecast by Type (2021-2026)

Table 39. Global Autologous Cell Therapy Revenue by Application (2016-2021)

Table 40. Global Autologous Cell Therapy Revenue Forecast by Application (2021-2026)

Table 41. North America Autologous Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 42. North America Autologous Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 43. North America Autologous Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 44. North America Autologous Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 45. North America Autologous Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 46. North America Autologous Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 47. Europe Autologous Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 48. Europe Autologous Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 49. Europe Autologous Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 50. Europe Autologous Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 51. Europe Autologous Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 52. Europe Autologous Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 53. Asia-Pacific Autologous Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 54. Asia-Pacific Autologous Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 55. Asia-Pacific Autologous Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 56. Asia-Pacific Autologous Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 57. Asia-Pacific Autologous Cell Therapy Revenue by Region (2016-2021) & (USD Million)

Table 58. Asia-Pacific Autologous Cell Therapy Revenue by Region (2021-2026) & (USD Million)

Table 59. South America Autologous Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 60. South America Autologous Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 61. South America Autologous Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 62. South America Autologous Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 63. South America Autologous Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 64. South America Autologous Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 65. Middle East & Africa Autologous Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 66. Middle East & Africa Autologous Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 67. Middle East & Africa Autologous Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 68. Middle East & Africa Autologous Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 69. Middle East & Africa Autologous Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 70. Middle East & Africa Autologous Cell Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Autologous Cell Therapy Picture

Figure 2. Global Autologous Cell Therapy Revenue Market Share by Type in 2020

Figure 3. Bone Marrow

Figure 4. Epidermis

Figure 5. Autologous Cell Therapy Revenue Market Share by Application in 2020

Figure 6. Neurology Picture

Figure 7. Orthopedics Picture

Figure 8. Cancer Picture

Figure 9. Wound Healing Picture

Figure 10. Other Picture

Figure 11. Global Autologous Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Autologous Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Autologous Cell Therapy Revenue Market Share by Region (2016-2026)

Figure 14. Global Autologous Cell Therapy Revenue Market Share by Region in 2020

Figure 15. North America Autologous Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Autologous Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Autologous Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Autologous Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Autologous Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Autologous Cell Therapy Market Drivers

Figure 21. Autologous Cell Therapy Market Restraints

Figure 22. Autologous Cell Therapy Market Trends

Figure 23. BioTime Recent Developments and Future Plans

Figure 24. Pharmicell Recent Developments and Future Plans

Figure 25. BrainStorm Cell Therapeutics Recent Developments and Future Plans

Figure 26. Opexa Therapeutics Recent Developments and Future Plans

Figure 27. Vericel Corporation Recent Developments and Future Plans

Figure 28. Regeneus Recent Developments and Future Plans

Figure 29. Global Autologous Cell Therapy Revenue Share by Players in 2020

Figure 30. Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 31. Global Top 3 Players Autologous Cell Therapy Revenue Market Share in 2020

Figure 32. Global Top 10 Players Autologous Cell Therapy Revenue Market Share in 2020

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 34. Global Autologous Cell Therapy Revenue Share by Type in 2020

Figure 35. Global Autologous Cell Therapy Market Share Forecast by Type (2021-2026)

Figure 36. Global Autologous Cell Therapy Revenue Share by Application in 2020

Figure 37. Global Autologous Cell Therapy Market Share Forecast by Application (2021-2026)

Figure 38. North America Autologous Cell Therapy Sales Market Share by Type (2016-2026)

Figure 39. North America Autologous Cell Therapy Sales Market Share by Application (2016-2026)

Figure 40. North America Autologous Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 41. United States Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Autologous Cell Therapy Sales Market Share by Type (2016-2026)

Figure 45. Europe Autologous Cell Therapy Sales Market Share by Application (2016-2026)

Figure 46. Europe Autologous Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 47. Germany Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Autologous Cell Therapy Sales Market Share by Type (2016-2026)

Figure 53. Asia-Pacific Autologous Cell Therapy Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Autologous Cell Therapy Revenue Market Share by Region (2016-2026)

Figure 55. China Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Japan Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. South Korea Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. India Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Australia Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South America Autologous Cell Therapy Sales Market Share by Type (2016-2026)

Figure 62. South America Autologous Cell Therapy Sales Market Share by Application (2016-2026)

Figure 63. South America Autologous Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 64. Brazil Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Argentina Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Middle East and Africa Autologous Cell Therapy Sales Market Share by Type (2016-2026)

Figure 67. Middle East and Africa Autologous Cell Therapy Sales Market Share by Application (2016-2026)

Figure 68. Middle East and Africa Autologous Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 69. Turkey Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. UAE Autologous Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source